Paper41462011
CCL20 secreted by KRT15high tumor Cells promotes tertiary lymphoid structure formation and enhances anti-PD-1 therapy response in HPV+HNSCC.
Zhang S and 12 others. Cell Death Dis, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. CCL20 secreted by KRT15high tumor Cells promotes tertiary lymphoid structure formation and enhances anti-PD-1 therapy response in HPV+HNSCC. Papers, record 41462011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41462011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CCL20 secreted by KRT15high tumor Cells promotes tertiary lymphoid structure formation and enhances anti-PD-1 therapy response in HPV+HNSCC.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tertiary Lymphoid Structures | Major topic |
| Chemokine CCL20 | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Papillomavirus Infections | Major topic |
| Programmed Cell Death 1 Receptor | Major topic |
| Head and Neck Neoplasms | Major topic |
| Immune Checkpoint Inhibitors | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Female | |
| Cell Line, Tumor | |
| Male |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023A1515220104 | Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) | PubMed | ||
| 82473326 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| JCYJ20240813101805007 | Shenzhen Science and Technology Innovation Commission | PubMed | ||
| JCYJ20240813101802004 | Shenzhen Science and Technology Innovation Commission | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35866777 | Upregulated keratin 15 links to the occurrence of lymphovascular invasion, stromal cervical invasion as well as unfavorable survival profile in endometrial cancer patients. | Medicine (Baltimore) | 2022 | https://conductscience.org/library/papers/35866777 | PubMed |
| 2 | 36814917 | Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis. | Front Immunol | 2023 | https://conductscience.org/library/papers/36814917 | PubMed |
| 3 | 39992403 | Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma. | Cancer Discov | 2025 | https://conductscience.org/library/papers/39992403 | PubMed |
| 4 | 39198425 | Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39198425 | PubMed |
| 5 | 33597522 | Inference and analysis of cell-cell communication using CellChat. | Nat Commun | 2021 | https://conductscience.org/library/papers/33597522 | PubMed |
| 6 | 34099645 | B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. | Nat Commun | 2021 | https://conductscience.org/library/papers/34099645 | PubMed |
| 7 | 33529452 | Characteristics of B lymphocyte infiltration in HPV+ head and neck squamous cell carcinoma. | Cancer Sci | 2021 | https://conductscience.org/library/papers/33529452 | PubMed |
| 8 | 33442422 | Prognostic significance of KRT19 in Lung Squamous Cancer. | J Cancer | 2021 | https://conductscience.org/library/papers/33442422 | PubMed |
| 9 | 24138885 | Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Immunity | 2013 | https://conductscience.org/library/papers/24138885 | PubMed |
| 10 | 22945646 | Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis. | Oncogene | 2013 | https://conductscience.org/library/papers/22945646 | PubMed |
| 11 | 26631268 | Stromal Fibroblasts Induce CCL20 through IL6/C/EBPβ to Support the Recruitment of Th17 Cells during Cervical Cancer Progression. | Cancer Res | 2015 | https://conductscience.org/library/papers/26631268 | PubMed |
| 12 | 34048897 | The depths of PD-1 function within the tumor microenvironment beyond CD8+ T cells. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/34048897 | PubMed |
| 13 | 34103704 | Cancer stem cell-immune cell crosstalk in tumour progression. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/34103704 | PubMed |
| 14 | 32707869 | The CCL20-CCR6 Axis in Cancer Progression. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32707869 | PubMed |
| 15 | 36512409 | Krt14 and Krt15 differentially regulate regenerative properties and differentiation potential of airway basal cells. | JCI Insight | 2023 | https://conductscience.org/library/papers/36512409 | PubMed |
| 16 | 32193227 | B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32193227 | PubMed |
| 17 | 28676156 | Anatomy of the Skin and the Pathogenesis of Nonmelanoma Skin Cancer. | Facial Plast Surg Clin North Am | 2017 | https://conductscience.org/library/papers/28676156 | PubMed |
| 18 | 31092904 | Tertiary lymphoid structures in the era of cancer immunotherapy. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/31092904 | PubMed |
| 19 | 38252116 | ASCL2 is a key regulator of the proliferation-differentiation equilibrium in the esophageal epithelium. | Biol Open | 2024 | https://conductscience.org/library/papers/38252116 | PubMed |
| 20 | 34381455 | BCR Affinity Influences T-B Interactions and B Cell Development in Secondary Lymphoid Organs. | Front Immunol | 2021 | https://conductscience.org/library/papers/34381455 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42810855 | Interleukin-33 alleviates the immunosuppressive tumor microenvironment and enhances anti-programmed death ligand-1 immunotherapy efficacy in hepatocellular carcinoma. | Chin Med J (Engl) | 2026 | https://conductscience.org/library/papers/42810855 | PubMed |
| 42540229 | Characterization of cancer-associated fibroblast populations that promote tertiary lymphoid structure formation in murine melanoma tumors. | Front Immunol | 2026 | https://conductscience.org/library/papers/42540229 | PubMed |
| 42316210 | CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42316210 | PubMed |
| 42193387 | Integrative Multi-Omics and Pan-Cancer Analyses Identify CCL20 as a Prognostic Biomarker with Therapeutic Relevance in Esophageal Cancer. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193387 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL20 | 6364 | PubTator's text mining | https://conductscience.org/library/genes/6364 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| ENTPD1 | 953 | PubTator's text mining | https://conductscience.org/library/genes/953 | NCBI Gene |
| KRT15 | 3866 | PubTator's text mining | https://conductscience.org/library/genes/3866 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41462011
GET https://conductscience.org/api/papers/v1/41462011/references?page=2